A means of improving public health in low- and middle-income countries? Benefits and challenges of international public-private partnerships
JournalArticle (Originalarbeit in einer wissenschaftlichen Zeitschrift)
 
ID 4118127
Author(s) Kostyak, L.; Shaw, D. M.; Elger, B.; Annaheim, B.
Author(s) at UniBasel Shaw, David
Elger, Bernice Simone
Annaheim, Beatrice
Kostyak, Laszlo
Year 2017
Title A means of improving public health in low- and middle-income countries? Benefits and challenges of international public-private partnerships
Journal Public health
Volume 149
Pages / Article-Number 120-129
Abstract In the last two decades international public-private partnerships have become increasingly important to improving public health in low- and middle-income countries. Governments realize that involving the private sector in projects for financing, innovation, development, and distribution can make a valuable contribution to overcoming major health challenges. Private-public partnerships for health can generate numerous benefits but may also raise some concerns. To guide best practice for public-private partnerships for health to maximize benefits and minimize risks, the first step is to identify potential benefits, challenges, and motives. We define motives as the reasons why private partners enter partnerships with a public partner.; We conducted a systematic review of the literature using the PRISMA guidelines.; We reviewed the literature on the benefits and challenges of public-private partnerships for health in low- and middle-income countries provided by international pharmaceutical companies and other health-related companies. We provide a description of these benefits, challenges, as well as of motives of private partners to join partnerships. An approach of systematic categorization was used to conduct this research.; We identified six potential benefits, seven challenges, and three motives. Our main finding was a significant gap in the available academic literature on this subject. Further empirical research using both qualitative and quantitative approaches is required. From the limited information that is readily available, we conclude that public-private partnerships for health imply several benefits but with some noticeable and crucial limitations.; In this article, we provide a description of these benefits and challenges, discuss key themes, and conclude that empirical research is required to determine the full extent of the challenges addressed in the literature.
Publisher Elsevier
ISSN/ISBN 0033-3506
edoc-URL http://edoc.unibas.ch/58079/
Full Text on edoc No
Digital Object Identifier DOI 10.1016/j.puhe.2017.03.005
PubMed ID http://www.ncbi.nlm.nih.gov/pubmed/28595064
ISI-Number WOS:000407538900020
Document type (ISI) Review
 
   

MCSS v5.8 PRO. 0.409 sec, queries - 0.000 sec ©Universität Basel  |  Impressum   |    
16/05/2022